OPKO Health
OPK
$1.25
Share price
0.00%
Change (1 day)
-19.35%
Change (1 year)
Categories
P/S ratio for OPKO Health (OPK)
P/S ratio as of June 2024 (TTM): 1.09
According to OPKO Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.08959. At the end of 2023 the company had a P/S ratio of 1.35.
P/S ratio history for OPKO Health from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.35 | 40.55% |
| 2022 | 0.9618 | -47.91% |
| 2021 | 1.85 | 0.16% |
| 2020 | 1.84 | 68.88% |
| 2019 | 1.09 | -38.74% |
| 2018 | 1.78 | -35.06% |
| 2017 | 2.74 | -35.33% |
| 2016 | 4.24 | -61.9% |
| 2015 | 11.1 | -76.49% |
| 2014 | 47.4 | 31.35% |
| 2013 | 36.1 | 15.46% |
| 2012 | 31.2 | -38.54% |
| 2011 | 50.8 | 89.59% |
| 2010 | 26.8 | -24.09% |
| 2009 | 35.3 | 3.57% |
| 2008 | 34.1 | |
| 2003 | 58.6 | 824.51% |
| 2002 | 6.34 | -84.32% |
| 2001 | 40.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.91 | 258.54% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.47 | 310.49% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 8.72 | 700.14% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 1.83 | 68.33% | 🇺🇸 USA |
 LabCorp LH | 1.37 | 25.71% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | 10.1 | 829.44% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.21 | 11.47% | 🇮🇱 Israel |
 Ardelyx ARDX | 9.34 | 757.01% | 🇺🇸 USA |